Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Cerevel Therapeutics Holdings, Inc.
  6. Consensus
    CERE   US15678U1280

CEREVEL THERAPEUTICS HOLDINGS, INC.

(CERE)
  Report
Real-time Estimate Cboe BZX  -  05/16 03:39:28 pm EDT
25.23 USD   +5.54%
05/11Berenberg Bank Adjusts Cerevel Therapeutics Holdings Price Target to $44 From $46, Maintains Buy Rating
MT
05/10Cerevel Therapeutics Q1 Loss Widens
MT
05/10CEREVEL THERAPEUTICS HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on CEREVEL THERAPEUTICS HOLDINGS, INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) CEREVEL THERAPEUTICS HOLDINGS, INC.
Analyst Recommendations on CEREVEL THERAPEUTICS HOLDINGS, INC.
05/11Berenberg Bank Adjusts Cerevel Therapeutics Holdings Price Target to $44 From $46, Maintai..
MT
03/31Berenberg Bank Initiates Coverage on Cerevel Therapeutics Holdings With Buy Rating, $46 Pr..
MT
02/15Goldman Sachs Starts Cerevel Therapeutics Holdings at Neutral With $27 Price Target
MT
01/05JPMorgan Starts Cerevel Therapeutics Holdings at Overweight With $50 Price Target
MT
2021HC Wainwright Starts Cerevel Therapeutics Holdings at Buy With $50 Price Target
MT
2021CEREVEL THERAPEUTICS : Jefferies & Co Adjusts Cerevel Therapeutics Holdings PT to $37 From $30, Maintains Buy Rat..
MT
2021CEREVEL THERAPEUTICS : Morgan Stanley Adjusts Cerevel Therapeutics Holdings PT to $39 From $27, Maintains Overwei..
MT
More recommendations
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 23,90 $
Average target price 42,86 $
Spread / Average Target 79,3%
High Price Target 50,00 $
Spread / Highest target 109%
Low Price Target 28,00 $
Spread / Lowest Target 17,2%
Consensus detail
Consensus revision (last 18 months)